https://www.marketscreener.com/quote/stock/BIOFRONTERA-AG-473407/news/Biofrontera-enrolls-first-patient-to-phase-IIb-clinical-study-evaluating-Ameluz-BF-RhodoLED--37305386/?utm_source=telegram&utm_medium=social&utm_campaign=share